Effectiveness of the MyDiaMate application in reducing diabetes distress in adults with type 1 diabetes: Study protocol of the multi‐national, randomised‐controlled MyREMEDY trial
Study context
- Population
- Adults with T1D in four European countries (the Netherlands, Germany, Spain and the UK)planned
- Participants
- 660 adults
- Planned comparison
- MyDiaMate vs care as usual
- Primary endpoint
- Diabetes distress
- Follow-up
- 3 months
Methodological detailsmultinational, 2:1 randomisation, Questionnaires at 0 (baseline), 3 (effectiveness) and 6 months (follow-up), Secondary outcomes: emotional well-being, psychological self-efficacy, social engagement, fatigue, glycaemic outcomes; MyDiaMate log data passively collected, Linear mixed model analyses, including identification of the user subgroup that benefits most
- Multinational
- 2:1 randomisation
- Questionnaires at 0 (baseline), 3 (effectiveness) and 6 months (follow-up)
- Secondary outcomes: emotional well-being, psychological self-efficacy, social engagement, fatigue, glycaemic outcomes; MyDiaMate log data passively collected
- Linear mixed model analyses, including identification of the user subgroup that benefits most
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Effectiveness of the MyDiaMate application in reducing diabetes distress in adults with type 1 diabetes: Study protocol of the multi‐national, randomised‐controlled MyREMEDY trial. Diabet Med. Published 30 September 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →